Ras-associated small GTPases (Rabs) are specific regulators of intracellular vesicle trafficking. Interference with host cell vesicular transport is a hallmark of many intracellular pathogens, including the notable example Mycobacterium tuberculosis. We performed, by quantitative polymerase chain reaction, gene-expression analyses for selected Rab molecules in peripheral-blood mononuclear cells from patients with tuberculosis (TB) and healthy control subjects, to identify candidate genes that are critically involved in the host immune response. Comparison revealed significant differences in the expression of genes for Rab13, Rab24, and Rab33A. Rab33A gene expression was down-regulated in patients with TB and was predominantly expressed in CD8 + T cells. We excluded possible influences of differences in T cell percentages between the 2 study groups, demonstrating that Rab33A gene expression changes on the single-cell level. In vitro, Rab33A RNA expression was induced in T cells on activation and by dendritic cells infected with M. tuberculosis. Our findings identify Rab33A as a T cell regulatory molecule in TB and suggest its involvement in disease processes.
sponse mechanisms [2] . CD4 + as well as CD8 + T cells are essential mediators of protection against facultative intracellular pathogens such as M. tuberculosis [3, 4] . CD8 + T cells contribute to the antimycobacterial host response in manifold fashion, including (1) cytotoxicity mediated via a granule-dependent exocytosis pathway; (2) cytotoxicity mediated via Fas/Fas ligand interaction; (3) direct microbicidal activity; and (4) release of cytokines [5] . Among relevant cytokines, T cell-derived interferon (IFN)-g is central to the protective host immune response, both in mice and in humans [6, 7] . IFN-g is expressed on antigen-specific activation and leads to maturation of effector T cell functions and activation of infected macrophages. Macrophages play a dual role in the antimycobacterial host response: on the one hand, they restrict the growth of engulfed mycobacteria; on the other hand, they shield the pathogen from being extinguished [8] . M. tuberculosis resides in phagosomal vesicles, where complex interactions between pathogen and host have evolved. A crucial element of mycobacterial survival involves the blockade of phagosomal maturation, which normally leads to the death of the engulfed microbes [9] . In this process, the recruitment of regulatory enzymes to the phagosomal membrane is disrupted by M. tuberculosis. Ras-associated small GTPase (Rab) 5 and Rab7 are essential mediators of these fusion events; Rab5 accumulates in the membranes of M. tuberculosis-containing phagosomes, whereas recruitment of Rab7 is inhibited [9] . Rab molecules play decisive roles in the regulation of intracellular trafficking in various cell types and tissues [10] . In T cells, for example, Rab27A controls the exocytosis of lysosomes as an important step in the release of cytotoxic granules as part of antimicrobial T cell effector functions. More than 60 Rab family members presumably exist in humans, and some of them play vital roles in distinct diseases [11] ; nonetheless, the function of the majority of them remains unknown [10] . Broader implications for the crucial role played by regulatory GTPases against TB have arisen from mouse studies, in which LRG-47, a member of the IFN-g-inducible p47 GTPase family, has been shown to be essential for protection against TB [12] . On the basis of differential gene expression in microarray analyses of peripheral-blood mononuclear cells (PBMCs) from patients with TB and healthy control subjects, we selected 13 Rab candidates. Quantitative PCR (qPCR) analyses revealed 3 differentially expressed Rab candidates, which were further defined with respect to their cellular distribution. Moreover, the function of Rab33A was tentatively characterized in a model of M. tuberculosis infection.
PARTICIPANTS, MATERIALS, AND METHODS
Patients and control subjects. Patients with TB were recruited at the Asklepios Center for Respiratory Medicine and Thoracic Surgery. Diagnosis was based on chest radiography, and laboratory confirmation was based on mycobacterial culture analysis. Healthy control subjects without a history of clinical TB were recruited from the laboratory staff at the Max Planck Institute for Infection Biology and the hospital staff at the Asklepios Center.
Altogether, 53 patients with TB and 47 control subjects (table  1) were included in the present study. Because of limitations in specimen quantity, subgroups were randomly chosen for different experiments. All donors provided written, informed consent. This study was approved by the local ethics committees (ek.205-18.1) and was conducted in accordance with the Helsinki Declaration.
Preparation of PBMCs and magnetic cell sorting. Forty milliliters of heparinized peripheral venous blood was obtained from each patient with TB and control subject, and PBMCs were isolated on Ficoll gradients (Biochrom). For RNA isolation, cells were immediately mixed with TRIzol reagent (Invitrogen) and were frozen at Ϫ80ЊC until the RNA was extracted in accordance with the manufacturer's instructions. RNA content, purity, and integrity were determined by use of an Agilent 2100 bioanalyzer (Agilent Technologies). For flow cytometry and in vitro assays, cells were frozen in RPMI 1640 containing 10% fetal calf serum (FCS; Invitrogen) and 10% dimethyl sulfoxide (Sigma-Aldrich) in liquid nitrogen. Freshly isolated immune cell populations were enriched by magnetic cell sorting with microbead-labeled monoclonal antibodies against CD3, CD4, CD8, or CD14 (Miltenyi Biotec) and positive-selection or depletion columns (LS and AS separation columns; Miltenyi Biotec), in accordance with the manufacturer's instructions.
Real-time qPCR analysis. RNA was reverse-transcribed to cDNA as described elsewhere [13] . SYBR Green (Applied Biosystems) uptake in double-stranded DNA was measured by use of an ABI PRISM 7000 thermocycler (Applied Biosystems), in accordance with the manufacturer's instructions. We designed primer pairs by use of ABI PRISM Primer Express software (version 2.0.0; Applied Biosystems). Primer sequences are summarized in table 2. With the exception of the in vitro stimulation assays, for which b-glucuronidase was selected as the internal standard, glyceraldehyde-3-phosphate dehydrogenase was used as the internal control.
Flow cytometry.
Flow cytometry was performed to analyze the efficiency of magnetic cell sorting and to determine the percentages of T cells in the PBMC populations of 24 of the patients with TB and 20 of the control subjects. Percentages are based on gated PBMCs; cell debris was excluded on the basis of size and granularity. Antibodies against CD4-allophycocyanin (APC; clone RPA-T4; BD Pharmingen), CD3-fluorescein isothiocyanate (clone UCHT-1; BD Pharmingen), CD8-peridinin chlorophyll protein (clone SK1; BD Pharmingen), and CD14-APC-phycoerythrin (clone M5E2; BD Pharmingen) were used to stain immune cell population markers. The staining procedures used were the same as those described elsewhere [13] . A FACSCalibur 
flow cytometer and CellQuest software (BD Biosciences) were used for analyses. T cell percentages were determined by use of FCS Express software (version 2; De Novo Software).
In vitro stimulation assays. For in vitro T cell activation, PBMCs were incubated with either 10 mg/mL phytohemagglutinin (PHA) or 10 mL/mL CD3/CD28 Dynabeads (Dynal Biotech) for 4, 24, and 72 h in RPMI 1640 (Invitrogen) containing 5% male human AB serum (Sigma-Aldrich), 1% penicillin, and 1% streptomycin (Invitrogen). For stimulation of PBMCs, M. tuberculosis H37Rv strain-infected dendritic cells (DCs) and CD14 + monocytic cells were isolated, and cells/well (12-6 1 ϫ 10 well plate; Greiner Bio-One) were incubated for 5 days with 200 U/mL recombinant human granulocyte-macrophage colony-stimulating factor (Sigma-Aldrich) and 5 ng/mL recombinant human interleukin (IL)-4 (Biosource International) in RPMI 1640 containing 5% human serum. For infection of DCs with M. tuberculosis, log phase mycobacteria in RPMI 6 5 ϫ 10 1640 containing 10% FCS were added to DCs and were incubated for 3 h at 37ЊC in 5% CO 2 . Afterward, the supernatant was discarded, and PBMCs, prestimulated PBMCs, or 6 5 ϫ 10 selected CD4 + or CD8 + T cells in RPMI 1640 containing 5% FCS were added. Prestimulation of PBMCs was achieved by incubation with 10 mg/mL M. tuberculosis protein extract for 7 days at 37ЊC in 5% CO 2 ; after 2 days, 20 U/mL IL-2 (Strathmann Biotech) was added to the culture. M. tuberculosis H37Rv strain was cultured for 3 days in 7H11 medium (BD Biosciences). For DC infection, mycobacteria were resuspended and counted. M. tuberculosis proteins were extracted by use of Fast Protein Blue Matrix tubes (Qbiogene), in accordance with the manufacturer's instructions.
Confounding of Rab33A gene expression. Rab33A gene expression, as determined by qPCR, was analyzed for confounding of the differences in T cell percentages between the 2 study groups. To adjust for confounding, we used the following linear model:
where y is the measured gene expression, m is the overall mean (i.e., average of all expression data), p is the percentage of T cells in the respective PBMC population as a confounding factor, G is a binary factor (control subjects are encoded as G p 0, whereas patients with TB are encoded as G p 1), is p ϫ G the interaction effect of study group and T cell percentage, and is the residual. A significant interaction effect implies that there are differences in single-cell gene-expression levels in the specific cells under consideration between the patients with TB and the control subjects. In this case, measured gene-expression signals are a function of both the quantity of the specific cells in the respective PBMC population as well as their single-cell geneexpression levels.
Statistical analysis of T cell percentages and gene expression. Differences in T cell percentages, as measured by flow cytometry, and in Rab candidate gene expression were assessed by the Mann-Whitney U test. All reported P values are nominal and are not adjusted for multiple testing. P ! .05 was considered to be statistically significant.
RESULTS

qPCR analyses of Rab molecules in PBMCs.
In initial microarray experiments, molecules involved in intracellular trafficking processes-notably Rab family members-showed differential expression between PBMCs from the patients with TB and those from the control subjects (authors' unpublished data). To follow up on these results, we chose 13 Rab candidates that showed a tendency toward differential gene expression for further evaluation. PBMCs from 23 of the patients with TB and 29 of the control subjects were analyzed by qPCR for gene expression of the Rab candidates. The genes for 3 of themRab33A, Rab24, and Rab13-were differentially expressed between the 2 study groups ( , , and , P ! .001 P p .005 P p .02 respectively) (figure 1). In the patients with TB, Rab33A was down-regulated, whereas Rab24 and Rab13 were up-regulated.
Preferential Rab33A gene expression in CD8 + T cells. Because relevant PBMC subpopulations for these Rab candidates are ill defined, we determined the levels of gene expression in + T cells ( figure 2B ). As expected, enrichment of CD3 + T cells increased Rab33A RNA levels, whereas enrichment of CD4 + T cells had hardly any effect. In contrast, enrichment of CD8 + T cells caused a 5-fold increase in Rab33A gene expression, compared with total gene expression in all PBMCs. These results suggested that Rab33A might be a novel CD8 + T cell factor that is relevant to adaptive immunity against TB; we therefore focused our study on Rab33A, to clarify the possible role that this molecule might play.
Absence of an effect of sex on Rab33A gene expression. Rab33A is an X chromosomally coded gene located at Xq26, a region that has been found to be associated with susceptibility to TB in an African population [14] . Accordingly, we analyzed the possible effect of sex on Rab33A gene expression by comparing groups of participants categorized by disease status and Figure 3 . Analysis of the potential effect of sex on Ras-associated small GTPase (Rab) 33A gene expression in patients with tuberculosis (TB) and healthy control subjects. Peripheral-blood mononuclear cells from 37 control subjects (21 female and 16 male) and 43 patients with TB (11 women and 32 men) were analyzed. Rab33A gene expression is shown as box plots for the patients with TB and the control subjects, categorized by sex; box plots and error bars represent the 5th, 25th, 50th, 75th, and 95th percentiles. All values are relative to the expression observed with glyceraldehyde-3-phosphate dehydrogenase. Asterisks indicate significant differences between the 2 study groups, as determined by the MannWhitney U test. sex. No difference between the male and the female control subjects was detected, but the male patients with TB, compared with the control subjects of either sex, had significantly downregulated Rab33A gene expression ( , for comparison P p .0001 with the female control subjects;
, for comparison with P p .003 the male control subjects) (figure 3). The differences between the female patients with TB and the male and the female control subjects were less pronounced but still reached significant levels ( , for comparison with the female control subjects; P p .03 , for comparison with the male control subjects) (figure P p .01 3). These results demonstrate the disease-specific decrease in Rab33A gene expression and render an effect of sex improbable.
Changes in T cell-dependent Rab33A gene expression on the single-cell level, revealed by adjustment for confounding. Differential transcript levels in the total PBMC population can be influenced by changes in the proportion of expressing cell subpopulations. Therefore, we performed flow cytometry to determine the T cell percentages in the patients with TB and the control subjects. Analyses revealed significantly decreased CD3 + T cell percentages ( ) in the patients with TB, P p .005 compared with those in the control subjects ( figure 4A) . Accordingly, we considered it to be important to determine whether differences in measured total gene-expression levels for Rab33A were caused by decreased T cell percentages or by differential gene expression on the single-cell level. Analysis of Rab33A gene expression in single cells was not feasible, because of a lack of specific antibodies. Therefore, we adjusted the Rab33A gene expression data for the confounding effect of the T cell percentages of individual participants. As was expected, we detected a significant dependence of Rab33A gene expression on T cell percentage in both study groups ( ) ( figure 4B ). P ! .001 However, we also determined that there was a significant difference in Rab33A gene expression between the T cell populations from the patients with TB and those from the control subjects ( ; ) (figure 4B). The less-severe slope F p 4.38 P p 0.04 1 for the patients with TB shown in figure 4B corresponds with decreased Rab33A gene expression in T cells on the single-cell level. In conclusion, our approach discriminates the confounding effect of T cell percentage and demonstrates cell-specific gene-expression differences for Rab33A. Induction of Rab33A gene expression in vitro on T cell activation and by M. tuberculosis-infected DCs. Limited information on the function of Rab33A is available [15] . Formerly known as S10, Rab33A was discovered during the early 1990s and was found to be expressed in the human T cell line Jurkat and the monocyte cell line U937 [15] . Rab33A fulfills all of the criteria for small GTPases and, therefore, likely plays a role in the regulation of intracellular vesicle transport or signaling. As a first step toward characterization of the function of Rab33A, we stimulated PBMCs in vitro with the T cell mitogen PHA or CD3/CD28 Dynabeads for various periods of time. Afterward, RNA levels for Rab33A and IFN-g were analyzed by qPCR. As was expected, IFN-g RNA levels were strongly increased after PHA or T cell receptor (TCR) stimulation; compared with the levels in unstimulated control wells, IFN-g RNA levels were increased --fold after only 4 h and then were 4 5 2 2 increased --fold after 24 h (figure 5A, bottom graph). Finally, we compared Rab33A gene expression in PBMCs from the patients with TB and the control subjects after in vitro T cell stimulation. PBMC samples were stimulated for 48 h with CD3/28 Dynabeads. We detected no significant difference between the 2 study groups, although median Rab33A gene expression was slightly higher in the control subjects (P p .64) (figure 6). Interestingly-and consistent with our M. tuberculosis-infected DC experiments (figure 5B)-no correlation between Rab33A gene expression and the amount of IFN-g RNA induced by stimulation was detected (data not shown).
DISCUSSION
Here we describe the involvement of regulatory molecules of the Rab family in the host immune response against TB. Three molecules-Rab33A, Rab24, and Rab13-showed differential expression in PBMCs from patients with TB versus healthy control subjects. Gene expression analyses of PBMC subpopulations revealed that Rab33A is a novel CD8 + T cell factor with significantly reduced gene expression in patients with TB. Rab33A gene expression was induced in vitro on PHA or TCR stimulation and by coculture with M. tuberculosis-infected DCs.
Strong evidence supports a decisive role for CD8 + T cells in the defense against TB, both in animal models [16, 17] and in human TB [18] . In humans, killing of M. tuberculosis in macrophages by CD8 + T cells via a perforin/granulysin-mediated process has been described [19] . At present, Rab27A is the bestdefined Rab family member related to cytotoxic CD8 + T cell functions (reviewed in [20, 21] ). Knowledge of the impact of Rab27A derives from a study in patients with Griscelli syndrome [22] as well as a study in mice [23] . In these studies, a functional mutation in the Rab27A gene impaired the release of secretory lysosomes by melanocytes and CD8 + T cells. The dramatic effect of Rab27A failure on CD8 + T cell function demonstrates that this Rab family member plays a decisive role in acquired immunity. Our own results for Rab27A imply an induction pattern comparable to that for Rab33A (data not shown). It is tempting to speculate that Rab33A plays a similar role in antigen-specific CD8 + T cell responses against TB. The gene encoding Rab33A is located on the X chromosome (Xq26) and is close to a region that has been found to be critical to susceptibility to TB in an African population [14, 24] . Our data demonstrate that, on TCR stimulation, PBMCs from patients with TB express Rab33A at a level comparable to that of PBMCs from control subjects. Nevertheless, a specific impact of genetic variations in Rab33A on susceptibility to TB has yet to be determined. Although further experiments are, likewise, needed to determine the precise biological role played by Rab33A in CD8 + T cell responses, our results demonstrate that this molecule qualifies as a candidate correlate of resistance against and susceptibility to TB. In the present study, Rab24, which was preferentially expressed in monocytes, was up-regulated in patients with TB. Rab24 may participate in fusion events between the endoplasmatic reticulum/cis-Golgi compartment and lysosomes that control autophagy processes [25, 26] . Induction of autophagy changes the distribution of Rab24, leading to its accumulation in autophagic vesicles [26] . Very recently, an important role for autophagy in the host immune response against M. tuberculosis infection has been observed [27] . This study revealed that autophagy abrogates the blockage of phagosome maturation, leading to increased M. tuberculosis elimination within macrophages. It remains to be determined whether autophagy processes are prevalent in PBMCs from patients with TB.
Our third candidate, up-regulated in PBMCs from patients with TB, was Rab13. Rab13 is preferentially expressed in epithelial cells, which are crucially involved in the regulation of functional tight junction assembly [28, 29] . Recently, the role played by Rab13 in this process was further clarified-Morimoto et al. demonstrated that Rab13 specifically regulates continuous endocytic recycling in epithelial cell lines [30] . In this study, a dominant active mutant (Rab13 Q67L) selectively inhibited the postendocytic recycling of occludin but not that of transferrin receptors. Endosomal recycling processes-and especially the transferrin-mediated iron metabolism-contribute to interactions between mycobacteria and host macrophages. In this way, M. tuberculosis improves its intracellular habitat [31] . Rab5 and Rab7 are key, well-defined regulators of phagosome maturation, a process that is targeted by M. tuberculosis [9] . It remains to be established whether Rab13 plays a similar role in the early endosome recycling of immune cells.
In the present study, the differences in mean gene expression of Rab candidates between the patients with TB and the control subjects were ∼2-fold (figure 1). These relatively slight differences are comparable with the results of studies that determined disease-specific expression patterns in PBMCs from patients with autoimmune disease and cancer [32] [33] [34] [35] . One cause of small differences is low percentages of gene-expressing PBMC subpopulations (e.g., CD8
+ T cells, in the case of Rab33A), which lead to the underestimating of differences in heterogeneous samples. Evidence for this derives from our cell-sorting experiments, in which depletion of CD4 + T cells had only a slight effect on Rab33A gene expression ( figure 2B ). This was due to the low proportions of originating cells and the relatively slight increase in CD8 + T cell percentage (from 10% before depletion to 18% after). In contrast, the enrichment of CD8 + T cells (to a percentage of 80%; figure 2B) led to a considerable increase in Rab33A gene expression. Nevertheless, that Rab33A gene expression did not vanish after CD8 + T cell depletion (to a percentage of 0.3%; figure 2B ) suggests a basal level of Rab33A gene expression in CD8
Ϫ cells, too.
In summary, our data emphasize the critical involvement of Rab family members in the host response against TB. Our data have also identified Rab33A as a novel CD8 + T cell factor that is likely involved in resistance against and susceptibility to the disease.
